135 related articles for article (PubMed ID: 27585649)
1. Design, purification and assessment of GRP78 binding peptide-linked Subunit A of Subtilase cytotoxic for targeting cancer cells.
Zhang L; Li Z; Shi T; La X; Li H; Li Z
BMC Biotechnol; 2016 Sep; 16(1):65. PubMed ID: 27585649
[TBL] [Abstract][Full Text] [Related]
2. Novel Aspects of the SubA Subunit of the Subtilase Cytotoxin.
Sessler K; Schmidt H; Barth H
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202183
[TBL] [Abstract][Full Text] [Related]
3. The Escherichia coli subtilase cytotoxin A subunit specifically cleaves cell-surface GRP78 protein and abolishes COOH-terminal-dependent signaling.
Ray R; de Ridder GG; Eu JP; Paton AW; Paton JC; Pizzo SV
J Biol Chem; 2012 Sep; 287(39):32755-69. PubMed ID: 22851173
[TBL] [Abstract][Full Text] [Related]
4. The enzyme subunit SubA of Shiga toxin-producing E. coli strains demonstrates comparable intracellular transport and cytotoxic activity as the holotoxin SubAB in HeLa and HCT116 cells in vitro.
Sessler K; Papatheodorou P; Wondany F; Krause M; Noettger S; Bernhard D; Michaelis J; Schmidt H; Barth H
Arch Toxicol; 2021 Mar; 95(3):975-983. PubMed ID: 33483759
[TBL] [Abstract][Full Text] [Related]
5. Low dose of GRP78-targeting subtilase cytotoxin improves the efficacy of photodynamic therapy in vivo.
Gabrysiak M; Wachowska M; Barankiewicz J; Pilch Z; Ratajska A; Skrzypek E; Winiarska M; Domagala A; Rygiel TP; Jozkowicz A; Boon L; Golab J; Firczuk M
Oncol Rep; 2016 Jun; 35(6):3151-8. PubMed ID: 27035643
[TBL] [Abstract][Full Text] [Related]
6. GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy.
Firczuk M; Gabrysiak M; Barankiewicz J; Domagala A; Nowis D; Kujawa M; Jankowska-Steifer E; Wachowska M; Glodkowska-Mrowka E; Korsak B; Winiarska M; Golab J
Cell Death Dis; 2013 Jul; 4(7):e741. PubMed ID: 23887632
[TBL] [Abstract][Full Text] [Related]
7. The occurrence of subtilase-cytotoxin-encoding genes in environmental Escherichia coli isolated from a Northern California estuary.
Pereira Md; Byrne BA; Nguyen TB; Lewis DJ; Atwill ER
Can J Microbiol; 2013 Jun; 59(6):437-41. PubMed ID: 23750960
[TBL] [Abstract][Full Text] [Related]
8. Targeting the unfolded protein response in glioblastoma cells with the fusion protein EGF-SubA.
Prabhu A; Sarcar B; Kahali S; Shan Y; Chinnaiyan P
PLoS One; 2012; 7(12):e52265. PubMed ID: 23284962
[TBL] [Abstract][Full Text] [Related]
9. Reconstructed mung bean trypsin inhibitor targeting cell surface GRP78 induces apoptosis and inhibits tumor growth in colorectal cancer.
Li Z; Zhao C; Li Z; Zhao Y; Shan S; Shi T; Li J
Int J Biochem Cell Biol; 2014 Feb; 47():68-75. PubMed ID: 24333163
[TBL] [Abstract][Full Text] [Related]
10. A subcytotoxic dose of subtilase cytotoxin prevents lipopolysaccharide-induced inflammatory responses, depending on its capacity to induce the unfolded protein response.
Harama D; Koyama K; Mukai M; Shimokawa N; Miyata M; Nakamura Y; Ohnuma Y; Ogawa H; Matsuoka S; Paton AW; Paton JC; Kitamura M; Nakao A
J Immunol; 2009 Jul; 183(2):1368-74. PubMed ID: 19553530
[TBL] [Abstract][Full Text] [Related]
11. Targeting the unfolded protein response in cancer therapy.
Backer MV; Backer JM; Chinnaiyan P
Methods Enzymol; 2011; 491():37-56. PubMed ID: 21329793
[TBL] [Abstract][Full Text] [Related]
12. Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells.
Backer JM; Krivoshein AV; Hamby CV; Pizzonia J; Gilbert KS; Ray YS; Brand H; Paton AW; Paton JC; Backer MV
Neoplasia; 2009 Nov; 11(11):1165-73. PubMed ID: 19881952
[TBL] [Abstract][Full Text] [Related]
13. A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli.
Paton AW; Srimanote P; Talbot UM; Wang H; Paton JC
J Exp Med; 2004 Jul; 200(1):35-46. PubMed ID: 15226357
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and apoptotic effects of recombinant subtilase cytotoxin variants of shiga toxin-producing Escherichia coli.
Funk J; Biber N; Schneider M; Hauser E; Enzenmüller S; Förtsch C; Barth H; Schmidt H
Infect Immun; 2015 Jun; 83(6):2338-49. PubMed ID: 25824835
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
Yun S; Han YS; Lee JH; Kim S; Lee SH
Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin.
Byres E; Paton AW; Paton JC; Löfling JC; Smith DF; Wilce MC; Talbot UM; Chong DC; Yu H; Huang S; Chen X; Varki NM; Varki A; Rossjohn J; Beddoe T
Nature; 2008 Dec; 456(7222):648-52. PubMed ID: 18971931
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of subtilase cytotoxin SubAB assembly.
Le Nours J; Paton AW; Byres E; Troy S; Herdman BP; Johnson MD; Paton JC; Rossjohn J; Beddoe T
J Biol Chem; 2013 Sep; 288(38):27505-27516. PubMed ID: 23921389
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery.
Liu Y; Steiniger SC; Kim Y; Kaufmann GF; Felding-Habermann B; Janda KD
Mol Pharm; 2007; 4(3):435-47. PubMed ID: 17373820
[TBL] [Abstract][Full Text] [Related]
19. GRP78 Regulates Apoptosis, Cell Survival and Proliferation in 5-Fluorouracil-resistant SNUC5 Colon Cancer Cells.
Lee JH; Yoon YM; Lee SH
Anticancer Res; 2017 Sep; 37(9):4943-4951. PubMed ID: 28870916
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78.
Zhao L; Li H; Shi Y; Wang G; Liu L; Su C; Su R
Int J Nanomedicine; 2015; 10():245-56. PubMed ID: 25565817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
